JP2023502794A5 - - Google Patents
Info
- Publication number
- JP2023502794A5 JP2023502794A5 JP2022554964A JP2022554964A JP2023502794A5 JP 2023502794 A5 JP2023502794 A5 JP 2023502794A5 JP 2022554964 A JP2022554964 A JP 2022554964A JP 2022554964 A JP2022554964 A JP 2022554964A JP 2023502794 A5 JP2023502794 A5 JP 2023502794A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- solvate
- salt
- alkyl
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19210073 | 2019-11-19 | ||
| EP19210073.3 | 2019-11-19 | ||
| PCT/EP2020/082778 WO2021099518A1 (en) | 2019-11-19 | 2020-11-19 | Novel compounds for the diagnosis, treatment and prevention of diseases associated with the aggregation of alpha-synuclein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502794A JP2023502794A (ja) | 2023-01-25 |
| JP2023502794A5 true JP2023502794A5 (cg-RX-API-DMAC7.html) | 2023-04-04 |
| JP7652791B2 JP7652791B2 (ja) | 2025-03-27 |
Family
ID=68834924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554964A Active JP7652791B2 (ja) | 2019-11-19 | 2020-11-19 | α－シヌクレインの凝集に関連する疾患の診断、治療および予防のための新規な化合物 |
Country Status (13)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210061202A (ko) | 2019-11-19 | 2021-05-27 | 일동제약(주) | 벤조나이트릴이 치환된 축합 피리미딘 유도체 및 그의 의약 용도 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| DE3169595D1 (en) | 1980-11-10 | 1985-05-02 | Gersonde Klaus | Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| DE3483949D1 (de) | 1983-09-26 | 1991-02-21 | Udo Dr Med Ehrenfeld | Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr. |
| DE3474511D1 (en) | 1983-11-01 | 1988-11-17 | Terumo Corp | Pharmaceutical composition containing urokinase |
| AU2935200A (en) | 1999-04-30 | 2000-11-17 | Pfizer Products Inc. | Compounds for the treatment of obesity |
| US6660753B2 (en) | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| US8829198B2 (en) * | 2007-10-31 | 2014-09-09 | Proteotech Inc | Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies |
| WO2004110351A2 (en) * | 2003-05-14 | 2004-12-23 | Anadys Pharmaceuticals, Inc. | Heterocyclic compounds for treating hepatitis c virus |
| DE102008020113A1 (de) * | 2008-04-23 | 2009-10-29 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dihydropyrazolone und ihre Verwendung |
| SI2004155T1 (en) * | 2006-03-29 | 2018-05-31 | Wista Laboratories Ltd. | Inhibitors of protein aggregation |
| US20110201686A1 (en) * | 2006-06-23 | 2011-08-18 | Yousef Al-Abed | Inhibitors of ASS and Synuclein Aggregation |
| JP4616237B2 (ja) | 2006-11-07 | 2011-01-19 | 日本電信電話株式会社 | シリコン化合物薄膜の形成方法 |
| EP2304366A2 (en) * | 2008-05-30 | 2011-04-06 | Foster Wheeler Energia Oy | Method of and system for generating power by oxyfuel combustion |
| EP2687513B1 (en) * | 2008-06-09 | 2020-12-02 | Ludwig-Maximilians-Universität München | Drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| TW201120016A (en) | 2009-12-08 | 2011-06-16 | Abbott Lab | Novel oxadiazole compounds |
| KR102671166B1 (ko) | 2015-12-14 | 2024-05-31 | 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. | 3,5-디페닐-디아졸 화합물의 수용성 유도체 |
| BR112018068066B1 (pt) * | 2016-03-11 | 2023-11-28 | Ac Immune Sa | Compostos bicíclicos e seu uso, composição diagnóstica e farmacêutica, misturas, métodos de coleção de dados para diagnóstico, para determinar uma predisposição a, para monitorar transtorno residual e para prever a capacidade de resposta de um paciente sofrendo de transtorno ou anormalidade associado com agregados de alfa-sinucleína, métodos para determinar a quantidade de agregados de alfa-sinucleína e para preparar um composto, kit teste e kit para preparar uma preparação radio farmacêutica |
| US20210261561A1 (en) | 2018-04-23 | 2021-08-26 | Shionogi & Co., Ltd. | Bicyclic heterocycle derivatives having selective bace1 inhibitory activity |
-
2020
- 2020-11-19 EP EP24166495.2A patent/EP4368184A3/en active Pending
- 2020-11-19 AU AU2020386151A patent/AU2020386151B2/en active Active
- 2020-11-19 PH PH1/2022/551224A patent/PH12022551224A1/en unknown
- 2020-11-19 EP EP20810960.3A patent/EP4061807A1/en active Pending
- 2020-11-19 MX MX2022005914A patent/MX2022005914A/es unknown
- 2020-11-19 KR KR1020227020703A patent/KR20220104000A/ko not_active Ceased
- 2020-11-19 WO PCT/EP2020/082778 patent/WO2021099518A1/en not_active Ceased
- 2020-11-19 US US17/777,571 patent/US20230067910A1/en active Pending
- 2020-11-19 BR BR112022008195A patent/BR112022008195A2/pt unknown
- 2020-11-19 JP JP2022554964A patent/JP7652791B2/ja active Active
- 2020-11-19 CA CA3160364A patent/CA3160364C/en active Active
- 2020-11-19 CN CN202080080990.8A patent/CN114728927B/zh active Active
-
2022
- 2022-05-10 IL IL292919A patent/IL292919B1/en unknown
- 2022-05-18 CL CL2022001302A patent/CL2022001302A1/es unknown
-
2023
- 2023-12-19 AU AU2023285721A patent/AU2023285721B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5086809B2 (ja) | ｍＰＧＥＳ−１阻害剤としての２−（フェニルまたはヘテロ環式）−１Ｈ−フェナントロ［９，１０−ｄ］イミダゾール | |
| WO2022222921A1 (zh) | 含哌嗪结构的parp抑制剂、其制备方法及医药用途 | |
| DK2748149T5 (en) | Pyridazinone compounds and their use as DAAO inhibitors | |
| MX2015004787A (es) | Compuestos antiviricos para el virus sincitial respiratorio. | |
| EP3555070A1 (en) | Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof | |
| JP2009526037A (ja) | トリアゾロピリジン化合物 | |
| KR20020067589A (ko) | 페닐피페라지닐 유도체 | |
| JP2024505732A (ja) | ピリドピリミジノン系誘導体及びその製造方法と使用 | |
| HUE024989T2 (en) | Azaindole derivatives as ABI and SRC protein kinase inhibitors | |
| IL298966A (en) | Bicyclic compound and application thereof | |
| JP2023520595A (ja) | ピラゾロピリダジノン化合物、その医薬組成物及びその用途 | |
| CN120418252A (zh) | Malt1抑制剂 | |
| WO2023069884A1 (en) | Kdm1a inhibitors for the treatment of disease | |
| JP2023502794A5 (cg-RX-API-DMAC7.html) | ||
| FR2846329A1 (fr) | Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique | |
| JP7493207B2 (ja) | がんの予防又は治療剤 | |
| JP2005530691A (ja) | 新規なチロインジシンとその関連プロセス、薬学的組成物および方法 | |
| EP1902054A1 (fr) | Derives de pyrido[2,3-d]pyrimidine, leur preparation, leur application en therapeutique | |
| JP2018536652A5 (cg-RX-API-DMAC7.html) | ||
| JP2021535924A (ja) | 新規なチアゾール誘導体及びその薬学的に許容される塩 | |
| FR2944792A1 (fr) | Derives de 1h-pyrazolo[4,3-c]isoquinoleines, leur preparation et leur application en therapeutique | |
| WO2022228512A1 (zh) | 作为Wee-1抑制剂的吡咯并嘧啶衍生物 | |
| FR2896246A1 (fr) | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. | |
| WO2022171088A1 (zh) | 吡唑并[3,4-d]嘧啶-3-酮衍生物 | |
| CN108341816A (zh) | 一种选择性抑制激酶化合物 |